BISCHOFBERGER NORBERT W — SEC Form 4 filings
SEC reporting owner CIK 1190273. 10 Form 4 filings on record with FilingPulse; latest filed 2026-05-28.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-16 to 2026-05-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 2 filings — 3,620,640 shares, $3,852,882 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: purchase of 1,378,901 shares @ $0.88 ($1,208,469) in Kronos Bio, Inc., filed 2024-06-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kronos Bio, Inc. (KRON) | Director, 10% owner | 4 | 5 legs · 3,620,640 sh · $3,852,882 | — | 11 |
| Vir Biotechnology, Inc. (VIR) | Director | 4 | — | — | 9 |
| Morphic Holding, Inc. (MORF) | Director | 2 | — | — | 7 |
Form 4 filings — BISCHOFBERGER NORBERT W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-28 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Kronos Bio, Inc. (KRON) | Code (U): 10,802,138 @ $0.57 · Code (U): 263,750 @ $0.57 · Code (U): 263,750 @ $0.57 · Code (U): 263,750 @ $0.57 · Code (U): 263,750 @ $0.57 · Disposition to issuer (D): 297,186 (derivative) @ $0 · +3 more | EDGAR |
| 2025-06-06 | 4 | Vir Biotechnology, Inc. (VIR) | Other (J): 10,667 @ $0 · Other (J): 10,667 @ $0 | EDGAR |
| 2025-06-02 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | Morphic Holding, Inc. (MORF) | Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 12,000 (derivative) · Disposition to issuer (D): 9,888 (derivative) · Disposition to issuer (D): 17,550 (derivative) · Disposition to issuer (D): 12,535 (derivative) · Disposition to issuer (D): 23,168 (derivative) | EDGAR |
| 2024-07-01 | 4 | Kronos Bio, Inc. (KRON) | Purchase (P): 410,848 @ $1.17 · Purchase (P): 204,670 @ $1.25 | EDGAR |
| 2024-06-12 | 4 | Kronos Bio, Inc. (KRON) | Purchase (P): 1,378,901 @ $0.88 · Purchase (P): 744,308 @ $1.09 · Purchase (P): 881,913 @ $1.24 | EDGAR |
| 2024-06-05 | 4 | Morphic Holding, Inc. (MORF) | Grant/award (A): 23,168 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 16,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Kronos Bio, Inc. (KRON) | Grant/award (A): 270,339 @ $0 · Grant/award (A): 699,800 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1190273 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →